\ Scientific Presentations 2018
ASX Linkedin Twitter               
  1. Home
  2. Our Pipeline
  3. Scientific Presentations
  4. Scientific Presentations 2018

 

Scientific Presentations 2018

 

Presentation Title Conference Date
Clinical evaluation of a novel oncolytic immunotherapy agent, CAVATAK® in combination with immune checkpoint therapy in advanced cancer patients 2018 International Oncolytic Virus Conference (IOVC) – 11th Meeting, Oxford, United Kingdom  10 April 2018

 

 

Extended Investor Presentation* – January 2018

* Investor Presentation supplemented with previously released clinical and scientific information

Viralytics Limited
Suite 305, Level 3, 66 Hunter Street
Sydney NSW 2000 Australia
T: +61 (0)2 9988 4000 F: +61 (0)2 8068 6038

© Viralytics Limited 2018
This information does not take your circumstances into account. Read the relevant ASX releases, financial reports and prospectuses before making an investment decision. Shares in Viralytics Limited, ABN 12 010 657 351, are traded on the Australian Stock Exchange (ASX:VLA) and on the over-the-counter market (OTC: VRACY).